nach oben

Neuropsychology Review

Erschienen in:

24.05.2017 | Review

Heterogeneity of Neuropsychological Impairment in HIV Infection: Contributions from Mild Cognitive Impairment

verfasst von: Kathryn N. Devlin, Tania Giovannetti

Erschienen in: Neuropsychology Review | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Despite longstanding acknowledgement of the heterogeneity of HIV-associated neurocognitive disorders (HAND), existing HAND diagnostic methods classify according to the degree of impairment, without regard to the pattern of neuropsychological strengths and weaknesses. Research in mild cognitive impairment (MCI) has demonstrated that classifying individuals into subtypes by both their level and pattern of impairment, using either conventional or statistical methods, has etiologic and prognostic utility. Methods for characterizing the heterogeneity of MCI provide a framework that can be applied to other disorders and may be useful in clarifying some of the current challenges in the study of HAND. A small number of studies have applied these methods to examine the heterogeneity of neurocognitive function among individuals with HIV. Most have supported the existence of multiple subtypes of neurocognitive impairment, with some evidence for distinct clinicodemographic features of these subtypes, but a number of gaps exist. Following a review of diagnostic methods and challenges in the study of HAND, we summarize the literature regarding conventional and empirical subtypes of MCI and HAND and identify directions for future research regarding neurocognitive heterogeneity in HIV infection.

Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., et al. (2011). The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s and Dementia, 7(3), 270–279.

Alexopoulos, P., Grimmer, T., Perneczky, R., Domes, G., & Kurz, A. (2006). Progression to dementia in clinical subtypes of mild cognitive impairment. Dementia and Geriatric Cognitive Disorders, 22(1), 27–34.PubMedCrossRef

Antinori, A., Arendt, G., Becker, J. T., Brew, B. J., Byrd, D. A., Cherner, M., et al. (2007). Updated research nosology for HIV-associated neurocognitive disorders. Neurology, 69(18), 1789–1799. doi:10.1212/01.WNL.0000287431.88658.8b.PubMedPubMedCentralCrossRef

Aretouli, E., & Brandt, J. (2010). Everyday functioning in mild cognitive impairment and its relationship with executive cognition. International Journal of Geriatric Psychiatry, 25(3), 224–233.PubMedPubMedCentralCrossRef

Aylward, E. H., Henderer, J. D., McArthur, J. C., Brettschneider, P. D., Harris, G. J., Barta, P. E., & Pearlson, G. D. (1993). Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging. Neurology, 43, 2099–2104.PubMedCrossRef

Azar, A., Devlin, K., Mell, J. C., Giovannetti, T., Pirrone, V., Nonnemacher, M. R., et al. (2016). Mitochondrial haplogroup influences motor function in long-term HIV-1-infected individuals. PLoS One, 11(10), e0163772. doi:10.1371/journal.pone.0163772.

Back, C., Miller, B., & Cummings, J. (1998). Neurobiological basis of behavioral changes in HIV-1 encephalopathy. In W. G. van Gorp & S. L. Buckingham (Eds.), Practitioner’s guide to the neuropsychiatry of HIV/AIDS (pp. 42–64). New York: Guilford Press.

Bangen, K. J., Jak, A. J., Schiehser, D. M., Delano-Wood, L., Tuminello, E., Han, S. D., et al. (2010). Complex activities of daily living vary by mild cognitive impairment subtype. Journal of the International Neuropsychological Society: JINS, 16(4), 630–639.PubMedPubMedCentralCrossRef

Barulli, D., & Stern, Y. (2013). Efficiency, capacity, compensation, maintenance, plasticity: Emerging concepts in cognitive reserve. Trends in Cognitive Sciences. doi:10.1016/j.tics.2013.08.012.

Becker, J. T., Caldararo, R., Lopez, O. L., Dew, M. A., Dorst, S. K., & Banks, G. (1995). Qualitative features of the memory deficit associated with HIV infection and AIDS: cross-validation of a discriminant function classification scheme. Journal of Clinical and Experimental Neuropsychology, 17(1), 134–142. doi:10.1080/13803399508406588.PubMedCrossRef

Bell-McGinty, S., Lopez, O. L., Meltzer, C. C., Scanlon, J. M., Whyte, E. M., Dekosky, S. T., & Becker, J. T. (2005). Differential cortical atrophy in subgroups of mild cognitive impairment. Archives of Neurology, 62(9), 1393–1397.PubMedCrossRef

Beyrer, C. (2007). HIV epidemiology update and transmission factors: risks and risk contexts--16th international AIDS conference epidemiology plenary. Clinical Infectious Diseases: an official publication of the Infectious Diseases Society of America, 44(7), 981–987. doi:10.1086/512371.CrossRef

Bhatia, R., Ryscavage, P., & Taiwo, B. (2012). Accelerated aging and human immunodeficiency virus infection: emerging challenges of growing older in the era of successful antiretroviral therapy. Journal of Neurovirology, 18(4), 247–255. doi:10.1007/s13365-011-0073-y.PubMedCrossRef

Bickel, H., Mösch, E., Seigerschmidt, E., Siemen, M., & Förstl, H. (2006). Prevalence and persistence of mild cognitive impairment among elderly patients in general hospitals. Dementia and Geriatric Cognitive Disorders, 21(4), 242–250.PubMedCrossRef

Blackstone, K., Moore, D. J., Franklin, D. R., Clifford, D. B., Collier, A. C., Marra, C. M., et al. (2012). Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings. The Clinical Neuropsychologist, 26(6), 894–908. doi:10.1080/13854046.2012.694479.PubMedCrossRef

Bondi, M. W., & Smith, G. E. (2014). Mild cognitive impairment: a concept and diagnostic entity in need of input from neuropsychology. Journal of the International Neuropsychological Society, 20(2), 129–134.PubMedPubMedCentralCrossRef

Bondi, M. W., Edmonds, E. C., Jak, A. J., Clark, L. R., Delano-Wood, L., McDonald, C. R., et al. (2014). Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates. Journal of Alzheimer’s disease: JAD, 42(1), 275–289. doi:10.3233/JAD-140276.PubMedPubMedCentral

Boone, K. B., Pontón, M. O., Gorsuch, R. L., González, J. J., & Miller, B. L. (1998). Factor analysis of four measures of prefrontal lobe functioning. Archives of Clinical Neuropsychology, 13(7), 585–595.PubMedCrossRef

Bornstein, R. A., Pace, P., Rosenberger, P., Nasrallah, H. A., Para, M. F., Whitacre, C. C., & Fass, R. J. (1993). Depression and neuropsychological performance in asymptomatic HIV infection. American Journal of Psychiatry, 150(6), 922–927. doi:10.1176/ajp.150.6.922.PubMedCrossRef

Bowie, C. R., Grossman, M., Gupta, M., Oyewumi, L. K., & Harvey, P. D. (2014). Cognitive remediation in schizophrenia: efficacy and effectiveness in patients with early versus long-term course of illness. Early Intervention in Psychiatry, 8(1), 32–38. doi:10.1111/eip.12029.PubMedCrossRef

Bozoki, A., Giordani, B., Heidebrink, J. L., Berent, S., & Foster, N. L. (2001). Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss. Archives of Neurology, 58(3), 411–416.PubMedCrossRef

Brew, B. J. (2004). Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS, 18(Suppl 1), S75–S78 Journal Article.PubMedCrossRef

Brickman, A. M., Cabo, R., & Manly, J. J. (2006). Ethical issues in cross-cultural neuropsychology. Applied Neuropsychology, 13(2), 91–100. doi:10.1207/s15324826an1302_4.PubMedCrossRef

Brooks, B. L., Iverson, G. L., & White, T. (2007). Substantial risk of “accidental MCI” in healthy older adults: base rates of low memory scores in neuropsychological assessment. Journal of the International Neuropsychological Society: JINS, 13(3), 490–500. doi:10.1017/S1355617707070531.PubMedCrossRef

Busse, A., Hensel, A., Gühne, U., Angermeyer, M. C., & Riedel-Heller, S. G. (2006). Mild cognitive impairment: Long-term course of four clinical subtypes. Neurology, 67(12), 2176–2185.PubMedCrossRef

Butters, N., Grant, I., Haxby, J., Judd, L. L., Martin, A., McClelland, J., et al. (1990). Assessment of AIDS-related cognitive changes: recommendations of the NIMH workshop on neuropsychological assessment approaches. Journal of Clinical and Experimental Neuropsychology, 12(6), 963–978. doi:10.1080/01688639008401035.PubMedCrossRef

Carey, C. L., Woods, S. P., Gonzalez, R., Conover, E., Marcotte, T. D., Grant, I., & Heaton, R. K. (2004a). Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. Journal of Clinical and Experimental Neuropsychology, 26(3), 307–319. Journal Article. doi:10.1080/13803390490510031.PubMedCrossRef

Carey, C. L., Woods, S. P., Rippeth, J. D., Gonzalez, R., Moore, D. J., Marcotte, T. D., et al. (2004b). Initial validation of a screening battery for the detection of HIV-associated cognitive impairment. The Clinical Neuropsychologist, 18(2), 234–248. doi:10.1080/13854040490501448.PubMedCrossRef

Centers for Disease Control and Prevention. (2016). Diagnoses of HIV infection in the United States and dependent areas, 2015. HIV Surveillance Report, 27, 1–114.

Cherner, M., Masliah, E., Ellis, R. J., Marcotte, T. D., Moore, D. J., Grant, I., & Heaton, R. K. (2002). Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis. Neurology, 59(10), 1563–1567.PubMedCrossRef

Cherner, M., Letendre, S., Heaton, R. K., Durelle, J., Marquie-Beck, J., Gragg, B., & Grant, I. (2005). Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. Neurology, 64(8), 1343–1347. Journal Article. doi:10.1212/01.WNL.0000158328.26897.0D.PubMedCrossRef

Cicerone, K. D., Langenbahn, D. M., Braden, C., Malec, J. F., Kalmar, K., Fraas, M., et al. (2011). Evidence-based cognitive rehabilitation: updated review of the literature from 2003 through 2008. Archives of Physical Medicine and Rehabilitation, 92(4), 519–530. doi:10.1016/j.apmr.2010.11.015.PubMedCrossRef

Clark, L. R., Delano-Wood, L., Libon, D. J., McDonald, C. R., Nation, D. A., Bangen, K. J., et al. (2013). Are empirically-derived subtypes of mild cognitive impairment consistent with conventional subtypes? Journal of the International Neuropsychological Society : JINS, 19(6), 635–645. doi:10.1017/S1355617713000313.PubMedPubMedCentralCrossRef

Clifford, D. B. (2008). HIV-associated neurocognitive disease continues in the antiretroviral era. Topics in HIV Medicine, 16(2), 94–98 Journal Article.PubMed

Clifford, D. B., & Ances, B. M. (2013). HIV-associated neurocognitive disorder. The Lancet Infectious Diseases, 13(11), 976–986. doi:10.1016/S1473-3099(13)70269-X.PubMedPubMedCentralCrossRef

Cohen, R. A., Harezlak, J., Schifitto, G., Hana, G., Clark, U., Gongvatana, A., et al. (2010). Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era. Journal of Neurovirology, 16(1), 25–32.PubMedPubMedCentralCrossRef

Cohen, R. A., Seider, T. R., & Navia, B. (2015). HIV effects on age-associated neurocognitive dysfunction: premature cognitive aging or neurodegenerative disease? Alzheimer’s Research & Therapy, 7(1), 37.CrossRef

Coutinho, A., Porto, F., Duran, F., Prando, S., Ono, C., Feitosa, E., et al. (2015). Brain metabolism and cerebrospinal fluid biomarkers profile of non-amnestic mild cognitive impairment in comparison to amnestic mild cognitive impairment and normal older subjects. Alzheimer’s Research & Therapy, 7(1), 58.CrossRef

Cruse, B., Cysique, L. A., Markus, R., & Brew, B. J. (2012). Cerebrovascular disease in HIV-infected individuals in the era of highly active antiretroviral therapy. Journal of Neurovirology, 18(4), 264–276. doi:10.1007/s13365-012-0092-3.PubMedCrossRef

Cysique, L. A., Maruff, P., & Brew, B. J. (2004). Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts. Journal of Neurovirology, 10(6), 350–357. doi:10.1080/13550280490521078.PubMedCrossRef

Cysique, L. A., Maruff, P., & Brew, B. J. (2006). Variable benefit in neuropsychological function in HIV-infected HAART-treated patients. Neurology, 66(9), 1447–1450. Journal Article. doi:10.1212/01.wnl.0000210477.63851.d3.PubMedCrossRef

Damian, M., Hausner, L., Jekel, K., Richter, M., Froelich, L., Almkvist, O., et al. (2013). Single-domain amnestic mild cognitive impairment identified by cluster analysis predicts alzheimer’s disease in the European prospective DESCRIPA study. Dementia and Geriatric Cognitive Disorders, 36(1–2), 1–19.PubMedCrossRef

Dawes, S., Suarez, P., Casey, C. Y., Cherner, M., Marcotte, T. D., Letendre, S., et al. (2008). Variable patterns of neuropsychological performance in HIV-1 infection. Journal of Clinical and Experimental Neuropsychology, 30(6), 613–626. doi:10.1080/13803390701565225.PubMedPubMedCentralCrossRef

Deeks, S. G. (2011). HIV infection, inflammation, immunosenescence, and aging. Annual Review of Medicine, 62, 141–155. doi:10.1146/annurev-med-042909-093756.PubMedPubMedCentralCrossRef

Delano-Wood, L., Bondi, M. W., Sacco, J., Abeles, N., Jak, A. J., Libon, D. J., & Bozoki, A. (2009). Heterogeneity in mild cognitive impairment: differences in neuropsychological profile and associated white matter lesion pathology. Journal of the International Neuropsychological Society : JINS, 15(6), 906–914. doi:10.1017/S1355617709990257.PubMedPubMedCentralCrossRef

Delis, D. C., Peavy, G., Heaton, R. K., Butters, N., Salmon, D. P., Taylor, M., et al. (1995). Do patients with HIV-associated minor cognitive/motor disorder exhibit a “subcortical” memory profile? Evidence using the California verbal learning test. Assessment, 2(2), 151–165. doi:10.1177/107319119500200205.

Devlin, K. N., Gongvatana, A., Clark, U. S., Chasman, J. D., Westbrook, M. L., Tashima, K. T., et al. (2012). Neurocognitive effects of HIV, hepatitis C, and substance use history. Journal of the International Neuropsychological Society, 18(1), 68–78. doi:10.1017/S1355617711001408.PubMedCrossRef

Duara, R., Loewenstein, D. A., Potter, E., Appel, J., Greig, M. T., Urs, R., et al. (2008). Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease. Neurology, 71(24), 1986–1992.PubMedPubMedCentralCrossRef

Edmonds, E. C., Delano-Wood, L., Clark, L. R., Jak, A. J., Nation, D. A., McDonald, C. R., et al. (2015). Susceptibility of the conventional criteria for mild cognitive impairment to false-positive diagnostic errors. Alzheimer’s and Dementia, 11(4), 415–424.PubMedCrossRef

Ellis, R. J., Badiee, J., Vaida, F., Letendre, S., Heaton, R. K., Clifford, D., et al. (2011). CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS, 25(14), 1747–1751. doi:10.1097/QAD.0b013e32834a40cd.PubMedCrossRef

Eshghi, A., Haughton, D., Legrand, P., Skaletsky, M., & Woolford, S. (2011). Identifying groups: a comparison of methodologies. Journal of Data Science, 9, 271–291.

Espinosa, A., Alegret, M., Boada, M., Vinyes, G., Valero, S., Martínez-Lage, P., et al. (2009). Ecological assessment of executive functions in mild cognitive impairment and mild Alzheimer’s disease. Journal of the International Neuropsychological Society : JINS, 15(5), 751–757. doi:10.1017/S135561770999035X.PubMedPubMedCentralCrossRef

Ettenhofer, M. L., Foley, J., Castellon, S. A., & Hinkin, C. H. (2010). Reciprocal prediction of medication adherence and neurocognition in HIV/AIDS. Neurology, 74(15), 1217–1222. doi:10.1212/WNL.0b013e3181d8c1ca.PubMedPubMedCentralCrossRef

Farias, S. T., Mungas, D., Reed, B. R., Cahn-Weiner, D., Jagust, W., Baynes, K., & Decarli, C. (2008). The measurement of everyday cognition (ECog): Scale development and psychometric properties. Neuropsychology, 22(4), 531–544. doi:10.1037/0894-4105.22.4.531.PubMedPubMedCentralCrossRef

Farias, S. T., Mungas, D., Harvey, D. J., Simmons, A., Reed, B. R., & DeCarli, C. (2011). The measurement of everyday cognition (ECog): development and validation of a short form. Alzheimer’s & Dementia : The Journal of the Alzheimer’s Association, 7(6), 593–601. doi:10.1016/j.jalz.2011.02.007.CrossRef

Fazeli, P. L., Crowe, M., Ross, L. A., Wadley, V., Ball, K., & Vance, D. E. (2014). Cognitive functioning in adults aging with HIV: a cross-sectional analysis of cognitive subtypes and influential factors. Journal of Clinical Research in HIV AIDS and Prevention, 1(4), 155–169. doi:10.14302/issn.2324-7339.jcrhap-13-191.PubMedPubMedCentralCrossRef

Fischer, P., Jungwirth, S., Zehetmayer, S., Weissgram, S., Hoenigschnabl, S., Gelpi, E., et al. (2007). Conversion from subtypes of mild cognitive impairment to Alzheimer dementia. Neurology, 68(4), 288–291.PubMedCrossRef

Foley, J., Ettenhofer, M., Wright, M. J., Siddiqi, I., Choi, M., Thames, A. D., et al. (2010). Neurocognitive functioning in HIV-1 infection: effects of cerebrovascular risk factors and age. The Clinical Neuropsychologist, 24(2), 265–285. doi:10.1080/13854040903482830.PubMedPubMedCentralCrossRef

Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12(3), 189–198.PubMedCrossRef

Forton, D. M., Allsop, J. M., Cox, I. J., Hamilton, G., Wesnes, K., Thomas, H. C., & Taylor-Robinson, S. D. (2005). A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection. AIDS, 19(Suppl 3), S53–S63 Journal Article.PubMedCrossRef

Ganguli, M., Snitz, B. E., Saxton, J. A, Chang, C.-C. H., Lee, C.-W., Vander Bilt, J., et al. (2011). Outcomes of mild cognitive impairment by definition: a population study. Archives of Neurology, 68(6), 761–767.

Giovannetti, T., Seligman, S. C., Britnell, P., Brennan, L., & Libon, D. J. (2015). Differential effects of goal cues on everyday action errors in Alzheimer’s disease versus Parkinson’s disease dementia. Neuropsychology, 29(4), 592–602. doi:10.1037/neu0000167.PubMedCrossRef

Gisslén, M., Price, R. W., & Nilsson, S. (2011). The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence? BMC Infectious Diseases, 11, 356. doi:10.1186/1471-2334-11-356.PubMedPubMedCentralCrossRef

Glymour, M. M., & Manly, J. J. (2008). Lifecourse social conditions and racial and ethnic patterns of cognitive aging. Neuropsychology Review. doi:10.1007/s11065-008-9064-z.

Goudsmit, J., Back, N. K., & Nara, P. L. (1991). Genomic diversity and antigenic variation of HIV-1: links between pathogenesis, epidemiology and vaccine development. The FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 5(10), 2427–2436.

Grant, I., Franklin, D. R., Deutsch, R., Woods, S. P., Vaida, F., Ellis, R. J., et al. (2014). Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline. Neurology, 82(23), 2055–2062. doi:10.1212/WNL.0000000000000492.PubMedPubMedCentralCrossRef

Han, J. W., Kim, T. H., Lee, S. B., Park, J. H., Lee, J. J., Huh, Y., et al. (2012). Predictive validity and diagnostic stability of mild cognitive impairment subtypes. Alzheimer’s and Dementia, 8(6), 553–559.PubMedCrossRef

Hanfelt, J. J., Wuu, J., Sollinger, A. B., Greenaway, M. C., Lah, J. J., Levey, A. I., & Goldstein, F. C. (2011). An exploration of subgroups of mild cognitive impairment based on cognitive, neuropsychiatric and functional features: analysis of data from the National Alzheimer’s Coordinating Center. The American Journal of Geriatric Psychiatry : official journal of the American Association for Geriatric Psychiatry, 19(11), 940–950.CrossRef

He, J., Farias, S., Martinez, O., Reed, B., Mungas, D., & DeCarli, C. (2009). Differences in brain volume, hippocampal volume, cerebrovascular risk factors, and apolipoprotein E4 among mild cognitive impairment subtypes. Archives of Neurology, 66(11), 1393–1399.PubMedPubMedCentralCrossRef

Heaton, R. K., Kirson, D., Velin, R., Grant, I., & the HNRC Group. (1994). The utility of clinical ratings for detecting cognitive change in HIV infection. In I. Grant & A. Markin (Eds.), Neuropsychology of HIV infection (pp. 188–206). New York: Oxford University Press.

Heaton, R. K., Grant, I., Butters, N., White, D. A., Kirson, D., Atkinson, J. H., et al. (1995). The HNRC 500-neuropsychology of HIV infection at different disease stages. Journal of the International Neuropsychological Society, 1(3), 231–251.PubMedCrossRef

Heaton, R. K., Clifford, D. B., Franklin Jr., D. R., Woods, S. P., Ake, C., Vaida, F., et al. (2010). HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER study. Neurology, 75(23), 2087–2096. Journal Article. doi:10.1212/WNL.0b013e318200d727.PubMedPubMedCentralCrossRef

Heaton, R. K., Franklin, D. R., Ellis, R. J., McCutchan, J. A., Letendre, S. L., LeBlanc, S., et al. (2011). HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: Differences in rates, nature, and predictors. Journal of Neurovirology, 17(1), 3–16.PubMedCrossRef

Hilsabeck, R. C., Perry, W., & Hassanein, T. I. (2002). Neuropsychological impairment in patients with chronic hepatitis C. Hepatology, 35(2), 440–446. Journal Article. doi:10.1053/jhep.2002.31257.PubMedCrossRef

Hilsabeck, R. C., Castellon, S. A., & Hinkin, C. H. (2005). Neuropsychological aspects of coinfection with HIV and hepatitis C virus. Clinical Infectious Diseases, 41(Suppl 1), S38–S44. Journal Article. doi:10.1086/429494.PubMedPubMedCentralCrossRef

Hughes, T. F., Snitz, B. E., & Ganguli, M. (2011). Should mild cognitive impairment be subtyped? Current Opinion in Psychiatry, 24(3), 237–242.PubMedPubMedCentralCrossRef

Hyman, B. T., Van Hoesen, G. W., Damasio, A. R., & Barnes, C. L. (1984). Alzheimer’s disease: cell-specific pathology isolates the hippocampal formation. Science (New York, N.Y.), 225(4667), 1168–1170. doi:10.1038/098448b0.CrossRef

Jack, C. R., Petersen, R. C., Xu, Y., O’Brien, P. C., Smith, G. E., Ivnik, R. J., et al. (1998). Rate of medial temporal lobe atrophy in typical aging and Alzheimer’s disease. Neurology, 51(4), 993–999. doi:10.1212/WNL.51.4.993.PubMedPubMedCentralCrossRef

Jak, A. J., Bangen, K. J., Wierenga, C. E., Delano-Wood, L., Corey-Bloom, J., & Bondi, M. W. (2009a). Contributions of neuropsychology and neuroimaging to understanding clinical subtypes of mild cognitive impairment. International Review of Neurobiology, 84, 81–103.

Jak, A. J., Bondi, M. W., Delano-Wood, L., Wierenga, C., Corey-Bloom, J., Salmon, D. P., & Delis, D. C. (2009b). Quantification of five neuropsychological approaches to defining mild cognitive impairment. The American Journal of Geriatric Psychiatry : official journal of the American Association for Geriatric Psychiatry, 17(5), 368–375. doi:10.1097/JGP.0b013e31819431d5.CrossRef

Jak, A. J., Urban, S., McCauley, A., Bangen, K. J., Delano-Wood, L., Corey-Bloom, J., & Bondi, M. W. (2009c). Profile of hippocampal volumes and stroke risk varies by neuropsychological definition of mild cognitive impairment. Journal of the International Neuropsychological Society, 15(6), 890. doi:10.1017/S1355617709090638.PubMedPubMedCentralCrossRef

Jernigan, T. L., Archibald, S., Hesselink, J. R., Atkinson, J. H., Velin, R. A., McCutchan, J. A., et al. (1993). Magnetic resonance imaging morphometric analysis of cerebral volume loss in human immunodeficiency virus infection. The HNRC Group. Archives of Neurology, 50(3), 250–255 Journal Article.PubMedCrossRef

Kim, K. R., Lee, K. S., Cheong, H.-K., Eom, J.-S., Oh, B. H., & Hong, C. H. (2009). Characteristic profiles of instrumental activities of daily living in different subtypes of mild cognitive impairment. Dementia and Geriatric Cognitive Disorders, 27(3), 278–285. doi:10.1159/000204765.PubMedCrossRef

Kizilbash, A. H., Vanderploeg, R. D., & Curtiss, G. (2002). The effects of depression and anxiety on memory performance. Archives of Clinical Neuropsychology : the official journal of the National Academy of Neuropsychologists, 17(1), 57–67. doi:10.1016/S0887-6177(00)00101-3.CrossRef

Knopman, D. S., Roberts, R. O., Geda, Y. E., Boeve, B. F., Pankratz, V. S., Cha, R. H., et al. (2009). Association of prior stroke with cognitive function and cognitive impairment: a population-based study. Archives of Neurology, 66(5), 614–619.PubMedPubMedCentralCrossRef

Knopman, D. S., Beiser, A., Machulda, M. M., Fields, J., Roberts, R. O., Pankratz, V. S., et al. (2015). Spectrum of cognition short of dementia: Framingham heart study and Mayo Clinic study of aging. Neurology, 85(19), 1712–1721. doi:10.1212/WNL.0000000000002100.PubMedPubMedCentralCrossRef

Köhler, S., Hamel, R., Sistermans, N., Koene, T., Pijnenburg, Y. A. L., Van Der Flier, W. M., et al. (2013). Progression to dementia in memory clinic patients without dementia: a latent profile analysis. Neurology, 81(15), 1342–1349.PubMedCrossRef

Letendre, S. L., McCutchan, J. A., Childers, M. E., Woods, S. P., Lazzaretto, D., Heaton, R. K., et al. (2004). Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders. Annals of Neurology, 56(3), 416–423. Journal Article. doi:10.1002/ana.20198.PubMedCrossRef

Libon, D. J., Xie, S. X., Eppig, J., Wicas, G., Lamar, M., Lippa, C., et al. (2010). The heterogeneity of mild cognitive impairment: a neuropsychological analysis. Journal of the International Neuropsychological Society : JINS, 16(1), 84–93. doi:10.1017/S1355617709990993.PubMedCrossRef

Lichter, D. G., & Cummings, J. L. (Eds.). (2011). Frontal-subcortical circuits in psychiatric and neurological disorders. New York: Guilford Press.

Lojek, E., & Bornstein, R. A. (2005). The stability of neurocognitive patterns in HIV infected men: classification considerations. Journal of Clinical and Experimental Neuropsychology, 27(6), 665–682. doi:10.1081/13803390490918426.PubMedCrossRef

Manly, J. J. (2005). Advantages and disadvantages of separate norms for African Americans. The Clinical Neuropsychologist, 19(2), 270–275. doi:10.1080/13854040590945346.PubMedCrossRef

Manly, J. J., & Echemendia, R. J. (2007). Race-specific norms: using the model of hypertension to understand issues of race, culture, and education in neuropsychology. Archives of Clinical Neuropsychology, 22(3), 319–325. doi:10.1016/j.acn.2007.01.006.PubMedCrossRef

Manly, J. J., Miller, S. W., Heaton, R. K., Byrd, D., Reilly, J., Velasquez, R. J., et al. (1998). The effect of African-American acculturation on neuropsychological test performance in normal and HIV-positive individuals. The HIV neurobehavioral research center (HNRC) group. Journal of the International Neuropsychological Society : JINS, 4(3), 291–302.PubMed

Manly, J. J., Jacobs, D. M., Touradji, P., Small, S. A., & Stern, Y. (2002). Reading level attenuates differences in neuropsychological test performance between African American and White elders. Journal of the International Neuropsychological Society : JINS, 8(3), 341–348. doi:10.1017/S1355617702813157.PubMedCrossRef

Manly, J. J., Byrd, D. A., Touradji, P., & Stern, Y. (2004). Acculturation, reading level, and neuropsychological test performance among African American elders. Applied Neuropsychology, 11(1), 37–46. doi:10.1207/s15324826an1101_5.PubMedCrossRef

Manly, J. J., Bell-McGinty, S., Tang, M.-X., Schupf, N., Stern, Y., & Mayeux, R. (2005). Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community. Archives of Neurology, 62(11), 1739–1746.PubMedCrossRef

Manly, J. J., Tang, M. X., Schupf, N., Stern, Y., Vonsattel, J. P. G., & Mayeux, R. (2008). Frequency and course of mild cognitive impairment in a multiethnic community. Annals of Neurology, 63(4), 494–506. doi:10.1002/ana.21326.PubMedPubMedCentralCrossRef

Mariani, E., Monastero, R., Ercolani, S., Mangialasche, F., Caputo, M., Feliziani, F. T., et al. (2007). Vascular risk factors in mild cognitive impairment subtypes: Findings from the ReGAl project. Dementia and Geriatric Cognitive Disorders, 24(6), 448–456.PubMedCrossRef

Martin-Thormeyer, E. M., & Paul, R. H. (2009). Drug abuse and hepatitis C infection as comorbid features of HIV associated neurocognitive disorder: neurocognitive and neuroimaging features. Neuropsychology Review, 19(2), 215–231. Journal Article. doi:10.1007/s11065-009-9101-6.

Masliah, E., Ge, N., Achim, C. L., DeTeresa, R., & Wiley, C. A. (1996). Patterns of neurodegeneration in HIV encephalitis. Journal of Neuro-AIDS, 1(1), 161–173.PubMedCrossRef

Matthews, F. E., Stephan, B. C. M., McKeith, I. G., Bond, J., & Brayne, C. (2008). Two-year progression from mild cognitive impairment to dementia: to what extent do different definitions agree? Journal of the American Geriatrics Society, 56(8), 1424–1433.PubMedCrossRef

McCutchan, J. A., Wu, J. W., Robertson, K., Koletar, S. L., Ellis, R. J., Cohn, S., et al. (2007). HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients. AIDS, 21(9), 1109–1117. Journal Article. doi:10.1097/QAD.0b013e3280ef6acd.PubMedCrossRef

McGuinness, B., Barrett, S. L., McIlvenna, J., Passmore, A. P., & Shorter, G. W. (2015). Predicting conversion to dementia in a memory clinic: a standard clinical approach compared with an empirically defined clustering method (latent profile analysis) for mild cognitive impairment subtyping. Alzheimer’s and Dementia: Diagnosis, Assessment and Disease Monitoring, 1(4), 447–454.PubMedPubMedCentral

Mitchell, A. J., & Shiri-Feshki, M. (2009). Rate of progression of mild cognitive impairment to dementia - meta-analysis of 41 robust inception cohort studies. Acta Psychiatrica Scandinavica, 119(4), 252–265.PubMedCrossRef

Monsuez, J.-J., Goujon, C., Wyplosz, B., Couzigou, C., Escaut, L., & Vittecoq, D. (2009). Cerebrovascular diseases in HIV-infected patients. Current HIV Research, 7(5), 475–480.PubMedCrossRef

Morgan, E. E., Woods, S. P., Delano-Wood, L., Bondi, M. W., & Grant, I. (2011). Intraindividual variability in HIV infection: evidence for greater neurocognitive dispersion in older HIV seropositive adults. Neuropsychology, 25(5), 645–654. doi:10.1037/a0023792.PubMedPubMedCentralCrossRef

Morgan, E. E., Woods, S. P., & Grant, I. (2012). Intra-individual neurocognitive variability confers risk of dependence in activities of daily living among HIV-seropositive individuals without HIV-associated neurocognitive disorders. Archives of Clinical Neuropsychology, 27(3), 293–303. doi:10.1093/arclin/acs003.PubMedPubMedCentralCrossRef

Mosconi, L., Tsui, W. H., Herholz, K., Pupi, A., Drzezga, A., Lucignani, G., et al. (2008). Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer’s disease, and other dementias. Journal of Nuclear Medicine : official publication, Society of Nuclear Medicine, 49(3), 390–398. doi:10.2967/jnumed.107.045385.CrossRef

Murji, S., Rourke, S. B., Donders, J., Carter, S. L., Shore, D., & Rourke, B. P. (2003). Theoretically derived CVLT subtypes in HIV-1 infection: internal and external validation. Journal of the International Neuropsychological Society : JINS, 9(1), 1–16.PubMedCrossRef

Muthén, L. K., & Muthén, B. O. (2012). Mplus User’s Guide (Seventh ed.). Los Angeles: Muthén & Muthén.

Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., et al. (2005). The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53(4), 695–699. doi:10.1111/j.1532-5415.2005.53221.x.PubMedCrossRef

Nightingale, S., Winston, A., Letendre, S., Michael, B. D., McArthur, J. C., Khoo, S., & Solomon, T. (2014). Controversies in HIV-associated neurocognitive disorders. The Lancet Neurology, 13(11), 1139–1151. doi:10.1016/S1474-4422(14)70137-1.PubMedPubMedCentralCrossRef

Nordlund, A., Rolstad, S., Klang, O., Edman, A., Hansen, S., & Wallin, A. (2010). Two-year outcome of MCI subtypes and aetiologies in the Göteborg MCI study. Journal of Neurology, Neurosurgery, and Psychiatry, 81(5), 541–546.PubMedCrossRef

Palmer, K., Backman, L., Winblad, B., & Fratiglioni, L. (2008). Mild cognitive impairment in the general population: occurrence and progression to Alzheimer disease. The American Journal of Geriatric Psychiatry : official journal of the American Association for Geriatric Psychiatry, 16(7), 603–611.CrossRef

Peavy, G., Jacobs, D., Salmon, D. P., Butters, N., Delis, D. C., Taylor, M., et al. (1994). Verbal memory performance of patients with human immunodeficiency virus infection: evidence of subcortical dysfunction. The HNRC Group. Journal of clinical and experimental neuropsychology, 16(4), 508. doi:10.1080/01688639408402662.PubMedCrossRef

Pedraza, O., & Mungas, D. (2008). Measurement in cross-cultural neuropsychology. Neuropsychology Review. doi:10.1007/s11065-008-9067-9.

Peraita, H., Chacon, J., Diaz-Mardomingo, C., & Martinez-Arias, R. (2015). Profiles of mild cognitive impairment (MCI) in the elderly. The Spanish Journal of Psychology, 18, E90. doi:10.1017/sjp.2015.96.PubMedCrossRef

Petersen, R. C. (2004). Mild cognitive impairment as a diagnostic entity. In Journal of Internal Medicine, 256, 183–194.CrossRef

Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999). Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology, 56(3), 303–308.PubMedCrossRef

Pike, K. E., Savage, G., Villemagne, V. L., Ng, S., Moss, S. A., Maruff, P., et al. (2007). Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer’s disease. Brain, 130(11), 2837–2844.PubMedCrossRef

Plessis, S. D., Vink, M., Joska, J. A., Koutsilieri, E., Stein, D. J., & Emsley, R. (2014). HIV infection and the fronto-striatal system: a systematic review and meta-analysis of fMRI studies. AIDS (London, England), 28(6), 803–811. doi:10.1097/QAD.0000000000000151.CrossRef

Power, C., Selnes, O. A., Grim, J. A., & McArthur, J. C. (1995). HIV dementia scale: a rapid screening test. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : official publication of the International Retrovirology Association, 8(3), 273–278.CrossRef

Prejean, J., Song, R., Hernandez, A., Ziebell, R., Green, T., Walker, F., et al. (2011). Estimated HIV incidence in the United States, 2006-2009. PLoS One, 6(8), e17502. doi:10.1371/journal.pone.0017502.

Ragin, A. B., Wu, Y., Storey, P., Cohen, B. A., Edelman, R. R., & Epstein, L. G. (2005). Diffusion tensor imaging of subcortical brain injury in patients infected with human immunodeficiency virus. Journal of Neurovirology, 11(3), 292–298. doi:10.1080/13550280590953799.PubMedPubMedCentralCrossRef

Rasquin, S., Lodder, J., Visser, P., Lousberg, R., & Verhey, F. (2005). Predictive accuracy of MCI subtypes for Alzheimer’s disease and vascular dementia in subjects with mild cognitive impairment: a 2-year follow-up study. Dementia and Geriatric Cognitive Disorders, 19, 113–119. doi:10.1159/000082662.PubMedCrossRef

Raz, N., Gunning, F. M., Head, D., Dupuis, J. H., McQuain, J., Briggs, S. D., et al. (1997). Selective aging of the human cerebral cortex observed in vivo: differential vulnerability of the prefrontal gray matter. Cerebral Cortex, 7(3), 268–282.PubMedCrossRef

Reger, M., Welsh, R., Razani, J., Martin, D. J., & Boone, K. B. (2002). A meta-analysis of the neuropsychological sequelae of HIV infection. Journal of the International Neuropsychological Society, 8(3), 410–424.PubMedCrossRef

Reitz, C., Tang, M.-X., Manly, J., Mayeux, R., & Luchsinger, J. A. (2007). Hypertension and the risk of mild cognitive impairment. Archives of Neurology, 64(12), 1734–1740. doi:10.1001/archneur.64.12.1734.PubMedPubMedCentralCrossRef

Riddoch, M. J., & Humphreys, G. W. (1994). Cognitive neuropsychology and cognitive rehabilitation. Hove: Lawrence Earlbaum Associates.

Rippeth, J. D., Heaton, R. K., Carey, C. L., Marcotte, T. D., Moore, D. J., Gonzalez, R., et al. (2004). Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. Journal of the International Neuropsychological Society, 10(1), 1–14. Journal Article. doi:10.1017/S1355617704101021.PubMedCrossRef

Roberts, R. O., Geda, Y. E., Knopman, D. S., Cha, R. H., Boeve, B. F., Ivnik, R. J., et al. (2010a). Metabolic syndrome, inflammation, and nonamnestic mild cognitive impairment in older persons: a population-based study. Alzheimer Disease and Associated Disorders, 24(1), 11–18.PubMedPubMedCentralCrossRef

Roberts, R. O., Knopman, D. S., Geda, Y. E., Cha, R. H., Roger, V. L., & Petersen, R. C. (2010b). Coronary heart disease is associated with non-amnestic mild cognitive impairment. Neurobiology of Aging, 31(11), 1894–1902.PubMedCrossRef

Robertson, K. R., Smurzynski, M., Parsons, T. D., Wu, K., Bosch, R. J., Wu, J., et al. (2007). The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS, 21(14), 1915–1921. Journal Article. doi:10.1097/QAD.0b013e32828e4e27.PubMedCrossRef

Ryan, E. L., Baird, R., Mindt, M. R., Byrd, D., Monzones, J., Bank, S. M, & Manhattan HIV Brain Bank. (2005). Neuropsychological impairment in racial/ethnic minorities with HIV infection and low literacy levels: effects of education and reading level in participant characterization. Journal of the International Neuropsychological Society : JINS, 11(7), 889–898. doi:10.1017/S1355617705051040.PubMedPubMedCentralCrossRef

Sachdev, P. S., Lipnicki, D. M., Crawford, J., Reppermund, S., Kochan, N. A., Trollor, J. N., et al. (2012). Risk profiles of subtypes of mild cognitive impairment: The sydney memory and ageing study. Journal of the American Geriatrics Society, 60(1), 24–33.PubMedCrossRef

Sacktor, N. C., Wong, M., Nakasujja, N., Skolasky, R. L., Selnes, O. A., Musisi, S., et al. (2005). The international HIV dementia scale: a new rapid screening test for HIV dementia. AIDS (London, England), 19(13), 1367–1374.

Sasaki, M., Kodama, C., Hidaka, S., Yamashita, F., Kinoshita, T., Nemoto, K., et al. (2009). Prevalence of four subtypes of mild cognitive impairment and APOE in a Japanese community. International Journal of Geriatric Psychiatry, 24(10), 1119–1126.PubMedCrossRef

Schwartz, M. F., Segal, M., Veramonti, T., Ferraro, M., & Buxbaum, L. J. (2002). The naturalistic action test: a standardised assessment for everyday action impairment. Neuropsychological Rehabilitation, 12(4), 311–339. doi:10.1080/09602010244000084.CrossRef

Seider, T. R., Luo, X., Gongvatana, A., Devlin, K. N., de la Monte, S. M., Chasman, J. D., et al. (2014). Verbal memory declines more rapidly with age in HIV infected versus uninfected adults. Journal of Clinical and Experimental Neuropsychology, 36(4), 356–367.PubMedPubMedCentralCrossRef

Sheppard, D. P., Iudicello, J. E., Bondi, M. W., Doyle, K. L., Morgan, E. E., Massman, P. J., et al. (2015). Elevated rates of mild cognitive impairment in HIV disease. Journal of Neurovirology, 21(5), 576–584. doi:10.1007/s13365-015-0366-7.PubMedPubMedCentralCrossRef

Siemieniuk, R. A. C., Beckthold, B., & John Gill, M. (2013). Increasing HIV subtype diversity and its clinical implications in a sentinel north American population. Canadian Journal of Infectious Diseases and Medical Microbiology, 24(2), 69–73.PubMedPubMedCentralCrossRef

Sohlberg, M. M., & Mateer, C. A. (2001). Cognitive rehabilitation: An integrative neuropsychological approach. New York: Guilford Press.

Sperling, R. A., Dickerson, B. C., Pihlajamaki, M., Vannini, P., LaViolette, P. S., Vitolo, O. V., et al. (2010). Functional alterations in memory networks in early alzheimer’s disease. NeuroMolecular Medicine. doi:10.1007/s12017-009-8109-7.

Stern, Y. (2002). What is cognitive reserve? Theory and research application of the reserve concept. Journal of the International Neuropsychological Society : JINS, 8(3), 448–460. doi:10.1017/S1355617702813248.PubMedCrossRef

Stern, R. A., Silva, S. G., Chaisson, N., & Evans, D. L. (1996). Influence of cognitive reserve on neuropsychological functioning in asymptomatic human immunodeficiency virus-1 infection. Archives of Neurology, 53(2), 148–153. doi:10.1001/archneur.1996.00550020052015.PubMedCrossRef

Summers, M. J., & Saunders, N. L. J. (2012). Neuropsychological measures predict decline to Alzheimer’s dementia from mild cognitive impairment. Neuropsychology, 26(4), 498–508.PubMedCrossRef

Tabert, M. H., Manly, J. J., Liu, X., Pelton, G. H., Rosenblum, S., Jacobs, M., et al. (2006). Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Archives of General Psychiatry, 63(8), 916–924.PubMedCrossRef

Tam, C. W. C., Lam, L. C. W., Chiu, H. F. K., & Lui, V. W. C. (2007). Characteristic profiles of instrumental activities of daily living in Chinese older persons with mild cognitive impairment. American Journal of Alzheimer’s Disease and Other Dementias, 22(3), 211–217.PubMedCrossRef

Tan, I. L., Smith, B. R., Hammond, E., Vornbrock-Roosa, H., Creighton, J., Selnes, O., et al. (2013). Older individuals with HIV infection have greater memory deficits than younger individuals. Journal of Neurovirology, 19(6), 531–536. doi:10.1007/s13365-013-0209-3.PubMedPubMedCentralCrossRef

Tedaldi, E. M., Minniti, N. L., & Fischer, T. (2015). HIV-associated neurocognitive disorders: the relationship of HIV infection with physical and social comorbidities. BioMed Research International, 2015, 641913. doi:10.1155/2015/641913.

Tozzi, V., Balestra, P., Bellagamba, R., Corpolongo, A., Salvatori, M. F., Visco-Comandini, U., et al. (2007). Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. Journal of Acquired Immune Deficiency Syndromes, 45(2), 174–182. Journal Article. doi:10.1097/QAI.0b013e318042e1ee.PubMedCrossRef

Underwood, J., Robertson, K. R., & Winston, A. (2015). Could antiretroviral neurotoxicity play a role in the pathogenesis of cognitive impairment in treated HIV disease? AIDS, 29(October 2014), 253–261. doi:10.1097/QAD.0000000000000538.PubMedCrossRef

Unverzagt, F. W., Gao, S., Baiyewu, O., Ogunniyi, A., Gureje, O., Perkins, A., et al. (2001). Prevalence of cognitive impairment data from the Indianapolis study of health and aging. Neurology, 57(9), 1655–1662.PubMedCrossRef

Valcour, V. G., Yee, P., Williams, A. E., Shiramizu, B., Watters, M., Selnes, O., et al. (2006). Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection--the Hawaii aging with HIV cohort. Journal of Neurovirology, 12(5), 387–391. Journal Article. doi:10.1080/13550280600915339.PubMedCrossRef

van de Pol, L. A., Verhey, F., Frisoni, G. B., Tsolaki, M., Papapostolou, P., Nobili, F., et al. (2009). White matter hyperintensities and medial temporal lobe atrophy in clinical subtypes of mild cognitive impairment: the DESCRIPA study. Journal of Neurology, Neurosurgery, and Psychiatry, 80, 1069–1074.PubMedCrossRef

van Gorp, W. G., Hinkin, C., Satz, P., Miller, E. N., Weisman, J., Holston, S., et al. (1993). Subtypes of HIV-related neuropsychological functioning: a cluster analysis approach. Neuropsychology, 7(1), 62–72. doi:10.1037/0894-4105.7.1.62.CrossRef

Veiel, H. O. F. (1997). A preliminary profile of neuropsychological deficits associated with major depression. Journal of Clinical and Experimental Neuropsychology, 19(4), 587–603. doi:10.1080/01688639708403745.PubMedCrossRef

Vemuri, P., Wiste, H. J., Weigand, S. D., Shaw, L. M., Trojanowski, J. Q., Weiner, M. W., et al. (2009). MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change. Neurology, 73(4), 294–301.PubMedPubMedCentralCrossRef

Visser, P. J., & Verhey, F. R. J. (2008). Mild cognitive impairment as predictor for Alzheimer’s disease in clinical practice: effect of age and diagnostic criteria. Psychological Medicine, 38, 113–122. doi:10.1017/S0033291707000554.PubMedCrossRef

Wilson, B. A. (1999). Case studies in neuropsychological rehabilitation. New York: Oxford University Press.

Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L.-O., et al. (2004). Mild cognitive impairment--beyond controversies, towards a consensus: report of the international working group on mild cognitive impairment. Journal of Internal Medicine, 256(3), 240–246. doi:10.1111/j.1365-2796.2004.01380.x.PubMedCrossRef

Wolk, D. A., Price, J. C., Saxton, J. A., Snitz, B. E., James, J. A., Lopez, O. L., et al. (2009). Amyloid imaging in mild cognitive impairment subtypes. Annals of Neurology, 65(5), 557–568.PubMedPubMedCentralCrossRef

Woods, S. P., Rippeth, J. D., Frol, A. B., Levy, J. K., Ryan, E., Soukup, V. M., et al. (2004). Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. Journal of Clinical and Experimental Neuropsychology, 26(6), 759–778. doi:10.1080/13803390490509565.PubMedCrossRef

Woods, S. P., Moore, D. J., Weber, E., & Grant, I. (2009). Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychology Review, 19(2), 152–168. Journal Article. doi:10.1007/s11065-009-9102-5.PubMedPubMedCentralCrossRef

Wykes, T., Huddy, V., Cellard, C., McGurk, S. R., & Czobor, P. (2011). A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. The American Journal of Psychiatry, 168(5), 472–485. doi:10.1176/appi.ajp.2010.10060855.PubMedCrossRef

Yadav, A., & Collman, R. G. (2009). CNS inflammation and macrophage/microglial biology associated with HIV-1 infection. Journal of Neuroimmune Pharmacology, 4(4), 430–447. doi:10.1007/s11481-009-9174-2.PubMedCrossRef

Yaffe, K., Petersen, R. C., Lindquist, K., Kramer, J., & Miller, B. (2006). Subtype of mild cognitive impairment and progression to dementia and death. Dementia and Geriatric Cognitive Disorders, 22(4), 312–319. doi:10.1159/000095427.PubMedCrossRef

Yeh, Y.-C., Lin, K.-N., Chen, W.-T., Lin, C.-Y., Chen, T.-B., & Wang, P.-N. (2011). Functional disability profiles in amnestic mild cognitive impairment. Dementia and Geriatric Cognitive Disorders, 31(3), 225–232. doi:10.1159/000326910.PubMedCrossRef

Zanetti, M., Ballabio, C., Abbate, C., Cutaia, C., Vergani, C., & Bergamaschini, L. (2006). Mild cognitive impairment subtypes and vascular dementia in community-dwelling elderly people: A 3-year follow-up study. Journal of the American Geriatrics Society, 54(4), 580–586.PubMedCrossRef

Titel: Heterogeneity of Neuropsychological Impairment in HIV Infection: Contributions from Mild Cognitive Impairment
verfasst von: Kathryn N. Devlin
Tania Giovannetti
Publikationsdatum: 24.05.2017
Verlag: Springer US
Erschienen in: Neuropsychology Review / Ausgabe 2/2017
Print ISSN: 1040-7308
Elektronische ISSN: 1573-6660
DOI: https://doi.org/10.1007/s11065-017-9348-2

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

16.04.2024 | Maligne primäre ZNS-Tumoren | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Heterogeneity of Neuropsychological Impairment in HIV Infection: Contributions from Mild Cognitive Impairment

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Manche Gestagene können das Risiko für Meningeome erhöhen

Parkinson: Größere Studie bestätigt Genauigkeit von Hauttest

Simple Kortisontherapie stoppt primär progrediente Aphasie

Impostor-Syndrom häufig bei Hyperhidrose zu finden

Update Neurologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2017

Neuropsychological Measures in the Arab World: A Systematic Review

Neuropsychological Test Administration by Videoconference: A Systematic Review and Meta-Analysis

Erratum to: The Differential Contributions of Conceptual Representation Format and Language Structure to Levels of Semantic Abstraction Capacity

Long-Term Neuropsychological Outcomes of Childhood Onset Acute Disseminated Encephalomyelitis (ADEM): a Meta-Analysis

The Differential Contributions of Conceptual Representation Format and Language Structure to Levels of Semantic Abstraction Capacity

Historical Perspectives on Ancient Greek Derived “a” Prefixed Nomenclature for Acquired Neurocognitive Impairment

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Manche Gestagene können das Risiko für Meningeome erhöhen

Parkinson: Größere Studie bestätigt Genauigkeit von Hauttest

Simple Kortisontherapie stoppt primär progrediente Aphasie

Impostor-Syndrom häufig bei Hyperhidrose zu finden

Update Neurologie